Intel CEO Reevaluating Fate of Next-Gen Chip Manufacturing Tech, CFO Confirms

Intel's leadership is conducting a high-stakes review of its next-generation manufacturing technology, with CEO Pat Gelsinger now reevaluating its long-term viability, according to the company's CFO. The decision comes amid mounting pressure to deliver on aggressive process node timelines, particularly for its Intel 18A and 14A nodes, which were previously slated for commercial rollout by 2026 and 2027, respectively. The review centers on whether to accelerate investment in existing 18A production or pivot toward alternative strategies, including potential partnerships or licensing of advanced process technology. Internal benchmarks show that yield rates on early 18A test wafers remain below target, with current performance at approximately 68%—well below the 85% threshold needed for high-volume production. This delay could push commercial deployments to late 2027, affecting Intel's ability to compete with TSMC's 3nm and 2nm nodes. The strategic shift would have ripple effects across the semiconductor ecosystem. Intel’s current foundry services, which aim to capture 10% of the global outsourced chip manufacturing market by 2030, could be scaled back or restructured. Meanwhile, competitors AMD and NVIDIA, both relying on TSMC for their advanced AI accelerators, may see a modest widening of their technological lead. Analysts project a 3–5 percentage point reduction in Intel’s foundry revenue forecast for 2027 if the technology path is altered. Investors reacted cautiously, with INTC shares slipping 1.8% in after-hours trading. NVDA and AMD saw modest gains of 0.9% and 1.3%, respectively, as market participants interpreted the news as a sign of Intel’s ongoing struggles in the process technology race. The potential shift underscores broader challenges in semiconductor capital intensity and the difficulty of catching up in a market dominated by mature players.